Maynard Um
-
-
-
-
-
-
-
Defence Therapeutics appoints Dr. Sarkis Meterissian to advisory board
-
-
-
-
-
-
-
Defence Therapeutics to Showcase Accum Platform at Key International Industry Events in March
-
-
-
-
-
-
-
Defence Therapeutics Sharpens Strategic Focus on Precision Drug Delivery to Unlock the Full Potential of Cancer Biologics
-
-
-
-
-
-
-
Defence Therapeutics Demonstrates Strong Preclinical in Vivo Efficacy Results Evaluating Accum-Kadcyla in Breast Cancer Models
-
-
-
-
-
-
-
Defence Therapeutics Completes Fully Subscribed Debenture Units Financing of $2,000,000
-
-
-
-
-
-
-
Defence Launches Accum Combined with Actinium-225 to Increase Efficacy and Safety of Radio-Immunoconjugate Cancer Therapies
-
-
-
-
-
-
-
Defence Provides Update on Delivery of AGSM Proxy Materials
-
406,069 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

